108 related articles for article (PubMed ID: 3601010)
1. Effects of cations on high-affinity binding of 3H-ADTN to dopaminergic sites in calf caudate tissue.
Lamont JS; Kula NS; Baldessarini RJ
Neuropharmacology; 1987 Jun; 26(6):637-9. PubMed ID: 3601010
[TBL] [Abstract][Full Text] [Related]
2. Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics.
List SJ; Wreggett KA; Seeman P
J Neurosci; 1982 Jul; 2(7):895-906. PubMed ID: 6124583
[TBL] [Abstract][Full Text] [Related]
3. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
Seeman P; Woodruff GN; Poat JA
Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of high-affinity binding of [3H](+/-)2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissue.
Arana GW; Baldessarini RJ; Lamont JS; Amlicke D; Neumeyer JL
Biochem Pharmacol; 1983 Oct; 32(19):2873-80. PubMed ID: 6626260
[TBL] [Abstract][Full Text] [Related]
5. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
Makman MH; Dvorkin B; Horowitz SG; Thal LJ
Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
[TBL] [Abstract][Full Text] [Related]
6. Binding of [3H]apomorphine to an aporphine binding site as well as to dopamine sites in tissue from bovine caudate nucleus.
Arana GW; Lamont JS; Baldessarini RJ; Teicher MH; Neumeyer JL; Cohen BM
Neuropharmacology; 1984 Aug; 23(8):885-92. PubMed ID: 6483116
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of ascorbate and EDTA on high-affinity binding of 3H-apomorphine and 3H-ADTN to calf caudate membranes.
Arana GW; Baldessarini RJ; Kula NS
Neuropharmacology; 1982 Jun; 21(6):601-4. PubMed ID: 6810198
[TBL] [Abstract][Full Text] [Related]
8. In vitro binding of the very potent and selective D-2 dopamine agonist, [3H]N-0437 to calf caudate membranes.
Van der Weide J; De Vries JB; Tepper PG; Horn AS
Eur J Pharmacol; 1987 Feb; 134(2):211-9. PubMed ID: 3569410
[TBL] [Abstract][Full Text] [Related]
9. Species variation in dopamine receptor binding.
Creese I; Stewart K; Snyder SH
Eur J Pharmacol; 1979 Nov; 60(1):55-66. PubMed ID: 520417
[TBL] [Abstract][Full Text] [Related]
10. Kinetic and pharmacological profiles of the in vitro binding of the potent dopamine agonist [3H]N,N-dipropyl-5,6-dihydroxy-2-aminotetralin to rat striatal membranes.
Mulder TB; Grol CJ; Dijkstra D; Horn AS
Eur J Pharmacol; 1985 May; 112(1):73-9. PubMed ID: 4018139
[TBL] [Abstract][Full Text] [Related]
11. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand.
Clement-Cormier Y; Abel M
Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):15-25. PubMed ID: 725314
[TBL] [Abstract][Full Text] [Related]
12. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
13. [3H]dopamine labeling of D3 dopaminergic sites in human, rat, and calf brain.
List SJ; Seeman P
J Neurochem; 1982 Nov; 39(5):1363-73. PubMed ID: 7119802
[TBL] [Abstract][Full Text] [Related]
14. D2- but not D3-dopamine receptors detected in the anterior pituitary.
Titeler M; Van Loon GR; Seeman P; Brown GM
Eur J Pharmacol; 1981 Apr; 71(1):143-6. PubMed ID: 7238583
[TBL] [Abstract][Full Text] [Related]
15. Ascorbic acid and membrane ageing: critical determinants of the in-vitro binding of [3H]ADTN to rat striatal tissue.
Bradbury AJ; Costall B; Naylor RJ
J Pharm Pharmacol; 1983 Nov; 35(11):738-45. PubMed ID: 6139456
[TBL] [Abstract][Full Text] [Related]
16. Binding of 3H-ADTN, a dopamine agonist, to membranes of the bovine retina.
Osborne NN
Cell Mol Neurobiol; 1981 Jun; 1(2):167-74. PubMed ID: 7346167
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
George SR; Watanabe M; Seeman P
J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
[TBL] [Abstract][Full Text] [Related]
18. Irreversible binding of [3H](-)N-chloroethylnorapomorphine to mammalian brain tissue.
Baldessarini RJ; Kula NS
Life Sci; 1983 Aug; 33(8):769-78. PubMed ID: 6193387
[TBL] [Abstract][Full Text] [Related]
19. [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalen (ADTN). Regional distribution and in vivo binding after acute and chronic drug treatment.
Clement-Cormier Y; Smith CE
Neurochem Res; 1980 Jun; 5(6):641-51. PubMed ID: 7402434
[TBL] [Abstract][Full Text] [Related]
20. S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects.
Rollema H; Feenstra MG; Grol CJ; Lewis MH; Staples L; Mailman RB
Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr; 332(4):338-45. PubMed ID: 3736679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
